Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Radiotherapy and Androgen Deprivation With or Without Docetaxel in Prostate Cancer
NCT03070886Phase 3Active, not recruiting
- Sponsor
- NRG Oncology
- Start
- Apr 2017
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by NRG Oncology. Started Apr 2017; status: active, not recruiting.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03070886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070886.